Add BrightSurf on Google Email

Large-scale study explores genetic link between colorectal cancer and meat intake

Researchers linked red/processed meat consumption to increased colorectal cancer risk, highlighting two genetic markers (HAS2 and SMAD7) that alter cancer risk levels based on meat intake. The study analyzed data from nearly 70,000 people and found a 30-40% increased risk for those with high red or processed meat intake.

SourceKeck School of Medicine of USC·JournalCancer Epidemiology Biomarkers & Prevention·TypeMeta-analysis·DateMar 14, 2024

Next generation stool DNA test has best detection rate of noninvasive colorectal cancer screening tools

A new study published in New England Journal of Medicine found that a next generation multi-target stool DNA colorectal cancer screening test detects 94 percent of colorectal cancers, outperforming other noninvasive tests. The test has the best detection rate for both colorectal cancer and advanced precancerous polyps.

SourceRegenstrief Institute·JournalNew England Journal of Medicine·DateMar 13, 2024

Clinical study of a blood test shows 83% accuracy for detecting colorectal cancer

A clinical study published in the New England Journal of Medicine found that a blood test can detect colorectal cancer in 83% of people confirmed to have the disease. The test, which analyzes circulating tumor DNA, offers an alternative to current screening options for patients who may decline traditional methods.

SourceFred Hutchinson Cancer Center·JournalNew England Journal of Medicine·TypeObservational study·DateMar 13, 2024

Most survivors of childhood cancer don't get the tests needed to detect serious long-term adverse effects

A study found that up to 87% of childhood cancer survivors are not following recommended screening guidelines, leaving them vulnerable to late effects such as heart disease and certain cancers. The lack of awareness and barriers to adherence may contribute to this low rate, highlighting the need for improved support and education.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·TypeObservational study·DateMar 11, 2024

The help of AI significantly improves colonoscopy

A new AI-powered system has been shown to detect 40% more polyps during colonoscopies, a crucial step in preventing colorectal cancer. This breakthrough technology uses artificial intelligence to examine every pixel in the image and alert doctors to potential issues, allowing for more accurate diagnoses.

SourceRadboud University Medical Center·JournalThe Lancet Digital Health·TypeRandomized controlled/clinical trial·DateFeb 22, 2024

Stemming colorectal cancer in Latin America

A recent study reveals the lack of colorectal cancer screening programs in low-middle-income countries, but successful implementation in high-middle-income Latin American nations. High-middle-income countries achieved high uptake of screening, with over 75% receiving colonoscopies following positive stool test results.

SourceRegenstrief Institute·JournalJAMA Network Open·DateFeb 20, 2024

Drug used for cocaine addiction may pave way for new treatment of advanced colon cancer

A new study from the University of Ottawa proposes using vanoxerine, a drug initially developed for cocaine addiction, to potentially treat advanced colon cancer. Vanoxerine has been found to suppress cancer stem cell activity in colon cancer patients' tissues and tumours implanted in laboratory animals. The drug works by interfering w...

SourceUniversity of Ottawa·JournalNature Cancer·TypeMeta-analysis·DateFeb 13, 2024

Ethnic disparities in cancer mortality in the capital and northeast of the State of São Paulo, Brazil

Cancer kills more Black people than White individuals in the Barretos region, whereas in São Paulo city, it is the opposite, according to a study published in Cancer Causes & Control. The disparity is most pronounced for breast and cervical cancer among Black women.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalCancer Causes & Control·TypeData/statistical analysis·DateJan 30, 2024

Obesity and alcohol are contributing to increases in bowel cancer rates among young adults

Experts predict a significant increase in bowel cancer death rates among young adults in the EU and UK, driven by rising obesity and heavy alcohol consumption. Death rates are predicted to rise by 26% in men and nearly 39% in women in the UK, with similar increases seen in Italy and other European countries.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·TypeData/statistical analysis·DateJan 28, 2024

Chinese Medical Journal review dives deep into probiotics for colorectal cancer

Researchers found that probiotics can limit CRC-promoting bacteria, rebalance the microbial profile, and induce targeted cancer cell death. Postbiotics derived from probiotic bacteria have also been shown to prevent CRC by limiting tumor proliferation and modulating the balance of anti-apoptotic and pro-apoptotic factors.

SourceCactus Communications·JournalChinese Medical Journal·TypeData/statistical analysis·DateDec 7, 2023

New Case Western Reserve University study finds diabetes drug may reduce risk for colorectal cancer

Researchers found that GLP-1 RAs significantly reduced the incidence of colorectal cancer in patients with diabetes, compared to those treated with other anti-diabetic drugs. The study's findings support the need for clinical trials to determine whether these medications could prevent one of the deadliest types of cancers.

SourceCase Western Reserve University·JournalJAMA Oncology·TypeData/statistical analysis·DateDec 7, 2023

Rare genetic variants better assessed

Researchers have developed gene-specific classification criteria for assessing the medical relevance of unclear genetic variants that can lead to hereditary colorectal cancer. The new criteria are expected to reclassify a significant proportion of these variants as harmless, providing relief to carriers worldwide.

SourceUniversitatsklinikum Bonn·JournalGenetics in Medicine·DateDec 6, 2023

Colorectal cancer in sub-Saharan Africa: Lack of basic care is costing lives

A new study found that most people with colorectal cancer in sub-Saharan Africa receive inadequate treatment, leading to significantly improved life expectancy through simple measures. The mortality rate is up to 3.5 times higher in regions studied compared to countries with medium HDI scores.

SourceMartin-Luther-Universität Halle-Wittenberg·JournalJournal of the National Comprehensive Cancer Network·TypeObservational study·DateNov 22, 2023

More than 10% of samples from a stool-based colorectal cancer test may be unsatisfactory

A study published in Cancer Epidemiology, Biomarkers & Prevention found that over 10% of fecal immunochemical tests used for routine colorectal cancer screening contained unsatisfactory samples. This led to fewer than half of patients completing follow-up testing within 15 months. The authors suggest potential solutions to improve comp...

SourceAmerican Association for Cancer Research·JournalCancer Epidemiology Biomarkers & Prevention·DateNov 15, 2023

Type 2 diabetes and colorectal cancer risk

A study of 54,000 participants found that diabetes was associated with an elevated risk of colorectal cancer. The association was attenuated for those who completed colonoscopies, highlighting the potential benefits of preventative screening.

SourceJAMA Network·JournalJAMA Network Open·DateNov 14, 2023

UTHealth Houston partners with Mexican organizations for $5 million NIH grant to improve implementation of cancer control interventions in Mexico and Latin America

The UTHealth Houston Institute for Implementation Science has received a five-year, $5 million grant from the National Cancer Institute to support research and training in implementation science. Researchers will focus on improving cancer control efforts in Mexico and Latin America.

Genetic switches in tumor development

Researchers at Kanazawa University found that genetic alterations underlie the dual function of activins in colorectal cancer. Mutations in genes such as Kras and Trp53 can promote tumor progression while also suppressing it, highlighting the complex role of TGF-ß signaling.

SourceKanazawa University·JournalCancer Research·DateNov 9, 2023

We can save lives and millions with less nitrate in drinking water

A new study by researchers at the University of Copenhagen finds that reducing nitrate levels in Danish drinking water could avoid 127 cases of colorectal cancer annually and save $300 million a year. Implementing stricter nitrate limits, such as lowering the maximum standard to 4 mg/L, can result in an additional $138 million saved.

SourceUniversity of Copenhagen - Faculty of Science·JournalScience of The Total Environment·DateNov 6, 2023

Major study validates Owkin’s best in class AI diagnostic for colorectal cancer biomarker aimed at optimizing patient access to immunotherapy

A recent study published in Nature Communications validates MSIntuit CRC, an AI-driven digital pathology diagnostic, as a reliable pre-screening tool for colorectal cancer. The diagnostic accurately rules out nearly 50% of MSS patients while correctly classifying over 96% of MSI patients.

SourceOwkin, Inc.·JournalNature Communications·TypeData/statistical analysis·DateNov 6, 2023

Can personalized care prevent over screening for colorectal cancer in older adults?

Researchers found that presenting adults between 76 and 85 with personalized information about the benefits and harms of colon cancer screening decreases excess screening. The study involved 431 older adults who received either standard or personalized care, with no significant differences in screening orders between the two groups.

SourceMichigan Medicine - University of Michigan·JournalJAMA Internal Medicine·TypeRandomized controlled/clinical trial·DateOct 30, 2023

Research group wins ERC Synergy grant for development of revolutionary colorectal cancer screening and treatment system

A research group led by Professor Kaspar Althoefer has been awarded a €10m ERC Synergy grant to develop a revolutionary new system for screening and treating colorectal cancer. The system, which combines medical robotics, artificial intelligence, and minimally invasive surgery, aims to improve patient outcomes and quality of life.

When family members of patients with colorectal cancer are invited to screening appointments themselves, just 1 in 3 go ahead with either fecal testing or colonoscopy, representing missed opportunities for early detection

A clinical trial in Spain found that only 1 in 3 family members of patients with colorectal cancer participate in screening, missing opportunities for early detection. The study used fecal testing and colonoscopy to screen first-degree relatives, but uptake was low.

SourcePLOS·JournalPLOS Medicine·DateOct 24, 2023

More Aggressive treatment doesn’t impact quality of life for metastatic colorectal cancer patients, according to new study in JNCCN

A new study published in JNCCN found that intensive local-regional treatment to remove as much tumor as possible did not significantly impact overall quality of life for patients with metastatic colorectal cancer. However, the treatment was associated with a higher risk of adverse events.

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·TypeData/statistical analysis·DateOct 12, 2023

Suppression of cancer stemness and drug resistance via BRAF/EGFR/MEK inhibition in colorectal cancer cells

Researchers discovered that inhibiting the BRAF/EGFR/MEK pathway significantly reduced cancer stemness and drug resistance in primary colorectal cancer cells. The study also identified a triple combination treatment against BRAF, EGFR, and MEK as a promising approach to block these activities and develop effective treatments.

SourceImpact Journals LLC·JournalOncotarget·TypeExperimental study·DateOct 11, 2023

Improving follow-up of abnormal cancer screening results

A multilevel primary care intervention, including electronic health record reminders and patient outreach, improved timely follow-up of overdue abnormal cancer screening test results for breast, cervical, colorectal, and lung cancer. The intervention was found to be effective in reducing missed screenings.

SourceJAMA Network·JournalJAMA·DateOct 10, 2023

Kinase-targeted therapy in subsets of colorectal cancer

Researchers explore kinase inhibitors as targeted therapies for specific CRC subsets, offering hope for improved treatment options. Key findings suggest that uncovering essential kinases for tumor growth can lead to more effective treatment strategies in metastatic or later-stage CRC patients.

SourceImpact Journals LLC·JournalOncoscience·TypeCommentary/editorial·DateSep 22, 2023

Kaiser Permanente cancer survival rates higher

Researchers found higher 5-year survival rates among Kaiser Permanente patients compared to National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) estimates. Improved screening rates, cancer treatment pathways, and coordinated care may have contributed to these higher survival rates.

SourceKaiser Permanente·JournalThe Permanente Journal·DateSep 20, 2023